Sol-Gel Technologies (SLGL) Current Assets (2016 - 2025)
Sol-Gel Technologies (SLGL) reported Current Assets of $27.0 million for Q4 2025, down 13.82% year-over-year from $31.3 million in Q4 2024, and down 14.79% on a QoQ basis from $31.7 million in Q3 2025.
Sol-Gel Technologies (SLGL) has 10 years of Current Assets data on file, last reported at $27.0 million in Q4 2025.
- Quarterly Current Assets fell 13.82% year-over-year to $27.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $27.0 million (down 13.82% YoY) and the FY2025 annual result came in at $27.0 million, down 13.82% from the prior year.
- Current Assets fell to $27.0 million in Q4 2025 per SLGL's latest filing, from $31.7 million in the prior quarter.
- Across five years, Current Assets topped out at $57.1 million in Q4 2021 and bottomed at $23.4 million in Q1 2025.
- The 5-year median for Current Assets is $41.3 million (2021), against an average of $41.1 million.
- The widest annual swing landed in 2021, when Current Assets sank 39.74%; it then rose 17.11% in 2022.
- Tracing SLGL's Current Assets over 5 years: stood at $57.1 million in 2021, then fell by 24.61% to $43.1 million in 2022, then decreased by 4.39% to $41.2 million in 2023, then retreated by 23.98% to $31.3 million in 2024, then dropped by 13.82% to $27.0 million in 2025.
- Per Business Quant, the three latest SLGL Current Assets figures stand at $27.0 million (Q4 2025), $31.7 million (Q3 2025), and $36.3 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Sol-Gel Technologies | 205.76 Mn | 194.73 Mn | - | 26.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.97 Mn |
| Sep 30, 2025 | 31.65 Mn |
| Jun 30, 2025 | 36.26 Mn |
| Mar 31, 2025 | 23.43 Mn |
| Dec 31, 2024 | 31.30 Mn |
| Sep 30, 2024 | 37.95 Mn |
| Jun 30, 2024 | 38.28 Mn |
| Mar 31, 2024 | 36.01 Mn |
| Dec 31, 2023 | 41.17 Mn |
| Sep 30, 2023 | 45.47 Mn |
| Jun 30, 2023 | 51.59 Mn |
| Mar 31, 2023 | 40.68 Mn |
| Dec 31, 2022 | 43.06 Mn |
| Sep 30, 2022 | 47.56 Mn |
| Jun 30, 2022 | 48.48 Mn |
| Mar 31, 2022 | 46.72 Mn |
| Dec 31, 2021 | 57.11 Mn |
| Sep 30, 2021 | 48.15 Mn |
| Jun 30, 2021 | 41.39 Mn |
| Mar 31, 2021 | 48.28 Mn |
| Dec 31, 2020 | 53.40 Mn |
| Sep 30, 2020 | 60.66 Mn |
| Jun 30, 2020 | 68.69 Mn |
| Mar 31, 2020 | 70.62 Mn |
| Dec 31, 2019 | 55.79 Mn |
| Sep 30, 2019 | 63.49 Mn |
| Jun 30, 2019 | 58.83 Mn |
| Mar 31, 2019 | 63.30 Mn |
| Dec 31, 2018 | 65.97 Mn |
| Sep 30, 2018 | 76.98 Mn |
| Jun 30, 2018 | 81.16 Mn |
| Mar 31, 2018 | 85.15 Mn |
| Dec 31, 2017 | 10.55 Mn |
| Dec 31, 2016 | 8.30 Mn |